| Category |
Transplantation |
| Manuscript Type |
Retrospective Study |
| Article Title |
''Minimizing tacrolimus'' strategy and long-term survival after liver transplantation
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jun-Jun Jia, Bin-Yi Lin, Jiang-Juan He, Lei Geng, Dhruba Kadel, Li Wang, Dong-Dong Yu, Tian Shen, Zhe Yang, Yu-Fu Ye, Lin Zhou and Shu-Sen Zheng |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National S and T Major Program |
2012ZX10002004 |
| National Natural Science Foundation of China |
81373160 |
| National Natural Science Foundation of China |
81302074 |
|
| Corresponding Author |
Correspondence to: Shu-Sen Zheng, MD, PhD, FACS, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital of Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou 310003, Zhejiang Province, China. shusenzheng@zju.edu.cn |
| Key Words |
Tacrolimus; Liver transplantation; Outcome; Minimizing tacrolimus; Immunosuppressive drug |
| Core Tip |
Liver transplantation (LT) is a life-saving technique for patients with end-stage liver disease. Tacrolimus (TAC) is the cornerstone immunosuppressant for prevention of graft rejection in many LT centers. However, frequent TAC-related toxicities are observed and these are a major concern in LT patients. Thus, the ‘‘minimizing tacrolimus’’ strategy after LT is very important, especially in the early phase. |
| Publish Date |
2014-08-29 11:57 |
| Citation |
Jia JJ, Lin BY, He JJ, Geng L, Kadel D, Wang L, Yu DD, Shen T, Yang Z, Ye YF, Zhou L, Zheng SS. “Minimizing tacrolimus’’ strategy and long-term survival after liver transplantation. World J Gastroenterol 2014; 20(32): 11363-11369 |
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i32/11363.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i32.11363 |
